Advanced Emissions Solutions, Inc Stock News

CTO Joe Wong to present on the fundamentals of activated carbon and product development efforts focused on PFAS sequestration and remediation CTO Joe Wong to present on the fundamentals of activated c

CEO Greg Marken to meet with institutional investors CEO Greg Marken to meet with institutional investors

Advanced Emissions Solutions, Inc. (NASDAQ:ADES ) Q4 2022 Earnings Conference Call March 9, 2023 9:00 AM ET Company Participants Ryan Coleman - Alpha IR Group Greg Marken - President, CEO & Treasurer

When it comes to penny stocks, a diligent look at fundamentals and insider activity should be key to your research. After all, penny stocks with strong insider buying can potentially be strong opportu

GREENWOOD VILLAGE, Colo., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the "Company" or "ADES") today announced the Company expects to release its fourth quarte

Penny stocks to buy according to insider trades this quarter. The post 3 Penny Stocks To Buy According To Insider Bets Up To $25 Million appeared first on Penny Stocks to Buy, Picks, News and Informat

Advanced Emissions Solutions, Inc. (NASDAQ:ADES ) Q3 2022 Earnings Conference Call November 9, 2022 9:00 AM ET Company Participants Ryan Coleman - Alpha IR Group Greg Marken - Chief Executive Officer,

Consumables revenue up 27% year-to-date driven by increased volumes and pricing initiatives

GREENWOOD VILLAGE, Colo., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”), a leader in emissions control solutions for coal-fire

GREENWOOD VILLAGE, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the "Company" or "ADES") today announced the Company expects to release its third quart

GREENWOOD VILLAGE, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the "Company" or "ADES") today announced the Company expects to release its third quarter

Elimination of asset retirement obligation strengthens the Company’s balance sheet and provides operational focus Elimination of asset retirement obligation strengthens the Company’s balance sheet

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Monday. The Dow traded down 2.01% to 33,030.06 while the NASDAQ fell 2.64% to 12,369.50.

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments